Plasma volume expansion across healthy pregnancy: a systematic review and meta-analysis of longitudinal studies.


Journal

BMC pregnancy and childbirth
ISSN: 1471-2393
Titre abrégé: BMC Pregnancy Childbirth
Pays: England
ID NLM: 100967799

Informations de publication

Date de publication:
19 Dec 2019
Historique:
received: 26 07 2019
accepted: 21 11 2019
entrez: 21 12 2019
pubmed: 21 12 2019
medline: 2 6 2020
Statut: epublish

Résumé

Plasma volume expansion is an important physiologic change across gestation. High or low expansion has been related to adverse pregnancy outcomes, yet there is a limited understanding of normal/healthy plasma volume expansion. We aimed to evaluate the pattern of plasma volume expansion across healthy pregnancies from longitudinal studies. We conducted a systematic review and meta-analysis to identify original studies that measured plasma volume in singleton pregnancies of healthy women. Specifically, we included studies that measured plasma volume at least two times across gestation and one time before or after pregnancy in the same women. PubMed, Web of Science, Cochrane, CINAHL, and clinicaltrials.gov databases were searched from the beginning of each database to February 2019. We combined data across studies using a random effects model. Ten observational studies with a total of 347 pregnancies were eligible. Plasma volume increased by 6% (95% CI 3-9) in the first trimester compared to the nonpregnant state. In the second trimester, plasma volume was increased by 18% (95% CI 12-24) in gestational weeks 14-20 and 29% (95% CI 21-36) in weeks 21-27 above the nonpregnant state. In the third trimester, plasma volume was increased by 42% (95% CI 38-46) in weeks 28-34 and 48% (95% CI 44-51) in weeks 35-38. The highest rate of increase occurred in the first half of the second trimester. Included studies were rated from moderate to high quality; 7 out of 10 studies were conducted over 30 years ago. In healthy pregnancies, plasma volume begins to expand in the first trimester, has the steepest rate of increase in the second trimester, and peaks late in the third trimester. The patterns observed from these studies may not reflect the current population, partly due to the changes in BMI over the last several decades. Additional longitudinal studies are needed to better characterize the range of normal plasma volume expansion across maternal characteristics.

Sections du résumé

BACKGROUND BACKGROUND
Plasma volume expansion is an important physiologic change across gestation. High or low expansion has been related to adverse pregnancy outcomes, yet there is a limited understanding of normal/healthy plasma volume expansion. We aimed to evaluate the pattern of plasma volume expansion across healthy pregnancies from longitudinal studies.
METHODS METHODS
We conducted a systematic review and meta-analysis to identify original studies that measured plasma volume in singleton pregnancies of healthy women. Specifically, we included studies that measured plasma volume at least two times across gestation and one time before or after pregnancy in the same women. PubMed, Web of Science, Cochrane, CINAHL, and clinicaltrials.gov databases were searched from the beginning of each database to February 2019. We combined data across studies using a random effects model.
RESULTS RESULTS
Ten observational studies with a total of 347 pregnancies were eligible. Plasma volume increased by 6% (95% CI 3-9) in the first trimester compared to the nonpregnant state. In the second trimester, plasma volume was increased by 18% (95% CI 12-24) in gestational weeks 14-20 and 29% (95% CI 21-36) in weeks 21-27 above the nonpregnant state. In the third trimester, plasma volume was increased by 42% (95% CI 38-46) in weeks 28-34 and 48% (95% CI 44-51) in weeks 35-38. The highest rate of increase occurred in the first half of the second trimester. Included studies were rated from moderate to high quality; 7 out of 10 studies were conducted over 30 years ago.
CONCLUSIONS CONCLUSIONS
In healthy pregnancies, plasma volume begins to expand in the first trimester, has the steepest rate of increase in the second trimester, and peaks late in the third trimester. The patterns observed from these studies may not reflect the current population, partly due to the changes in BMI over the last several decades. Additional longitudinal studies are needed to better characterize the range of normal plasma volume expansion across maternal characteristics.

Identifiants

pubmed: 31856759
doi: 10.1186/s12884-019-2619-6
pii: 10.1186/s12884-019-2619-6
pmc: PMC6924087
doi:

Types de publication

Journal Article Meta-Analysis Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

508

Références

Control Clin Trials. 1986 Sep;7(3):177-88
pubmed: 3802833
J Obstet Gynaecol Br Commonw. 1973 Dec;80(12):1067-74
pubmed: 4761381
BJOG. 2015 Dec;122(13):1773-80
pubmed: 26589850
Br J Obstet Gynaecol. 1979 May;86(5):364-70
pubmed: 465384
BMC Public Health. 2008 Jun 05;8:200
pubmed: 18533989
Stat Med. 2002 Jun 15;21(11):1539-58
pubmed: 12111919
JAMA. 2010 Jan 20;303(3):235-41
pubmed: 20071471
NCHS Data Brief. 2016 Jan;(232):1-8
pubmed: 26828319
Ann Intern Med. 2009 Aug 18;151(4):264-9, W64
pubmed: 19622511
Am J Physiol Regul Integr Comp Physiol. 2007 Sep;293(3):R1303-12
pubmed: 17609312
Hum Reprod. 2012 Sep;27(9):2613-8
pubmed: 22763372
Kidney Int. 1998 Dec;54(6):2056-63
pubmed: 9853271
Obstet Gynecol. 1996 Jul;88(1):33-9
pubmed: 8684758
Ultrasound Obstet Gynecol. 2017 Feb;49(2):177-187
pubmed: 28169502
PLoS Med. 2009 Jul 21;6(7):e1000100
pubmed: 19621070
Am J Clin Nutr. 1985 May;41(5):1032-41
pubmed: 3993606
JAMA. 2002 Oct 9;288(14):1723-7
pubmed: 12365955
Clin Haematol. 1985 Oct;14(3):601-12
pubmed: 4075604
J Obstet Gynaecol Br Commonw. 1966 Oct;73(5):717-23
pubmed: 5919090
JAMA. 2014 Feb 26;311(8):806-14
pubmed: 24570244
Biometrics. 1994 Dec;50(4):1088-101
pubmed: 7786990
J Obstet Gynaecol Br Emp. 1962 Oct;69:719-23
pubmed: 13941130
NCHS Data Brief. 2014 May;(152):1-8
pubmed: 24813228
Indian J Med Res. 1985 Dec;82:521-7
pubmed: 3833703
J Epidemiol Community Health. 1998 Jun;52(6):377-84
pubmed: 9764259
MMWR Morb Mortal Wkly Rep. 1989 Jun 9;38(22):400-4
pubmed: 2542755
Obstet Gynecol. 1994 Feb;83(2):265-9
pubmed: 8290192
Am J Med Sci. 2007 Jul;334(1):32-6
pubmed: 17630589
Cardiovasc J Afr. 2016 Mar-Apr;27(2):89-94
pubmed: 27213856
Am J Physiol Renal Physiol. 2016 Dec 1;311(6):F1125-F1134
pubmed: 27707703
Obstet Gynecol. 2011 May;117(5):1085-1093
pubmed: 21508747
JAMA. 2006 Apr 5;295(13):1549-55
pubmed: 16595758
Acta Obstet Gynecol Scand. 2000 Feb;79(2):89-98
pubmed: 10696955
J Obstet Gynaecol Br Commonw. 1973 Oct;80(10):884-7
pubmed: 4585824
ASAIO J. 2010 May-Jun;56(3):260-4
pubmed: 20335800
Am J Clin Nutr. 2017 Dec;106(Suppl 6):1620S-1625S
pubmed: 29070547
BMJ. 1997 Sep 13;315(7109):629-34
pubmed: 9310563
Int J Gynaecol Obstet. 1985 Apr;23(2):137-42
pubmed: 2862076
Am J Obstet Gynecol. 1967 Jun 1;98(3):394-403
pubmed: 5621454
BJOG. 2003 Nov;110(11):1001-6
pubmed: 14592585
J Nutr. 2012 Jun;142(6):1109-15
pubmed: 22535759
Hypertension. 2006 Feb;47(2):203-8
pubmed: 16380519
Br J Obstet Gynaecol. 1976 Feb;83(2):132-6
pubmed: 1032813
Obstet Gynecol. 2016 Sep;128(3):551-61
pubmed: 27500348
JAMA. 2012 Feb 1;307(5):491-7
pubmed: 22253363
Hypertension. 2015 Nov;66(5):1066-72
pubmed: 26370891
Int J Gynaecol Obstet. 1988 Feb;26(1):33-9
pubmed: 2892735
J Obstet Gynaecol Br Commonw. 1972 Aug;79(8):684-93
pubmed: 5070881
J Obstet Gynaecol Br Emp. 1958 Dec;65(6):877-94
pubmed: 13621287
Eur J Obstet Gynecol Reprod Biol. 1985 Oct;20(4):215-9
pubmed: 4054416
Br J Obstet Gynaecol. 1980 Jul;87(7):586-9
pubmed: 7426512
J Obstet Gynaecol Br Emp. 1963 Jun;70:402-7
pubmed: 13956023
MethodsX. 2019 May 08;6:1072-1083
pubmed: 31193322
BMJ. 2011 Jul 22;343:d4002
pubmed: 21784880
BMJ. 2003 Sep 6;327(7414):557-60
pubmed: 12958120

Auteurs

Sixtus Aguree (S)

110 Chandlee Laboratory, Department of Nutritional Sciences, The Pennsylvania State University, University Park, PA, 16802, USA.

Alison D Gernand (AD)

110 Chandlee Laboratory, Department of Nutritional Sciences, The Pennsylvania State University, University Park, PA, 16802, USA. adg14@psu.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH